Sfoglia per Autore
Two-Dimensional Shear Wave Elastography Versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C
2020-01-01 Villani, Rosanna; Cavallone, Francesco; Romano, ANTONINO DAVIDE; Bellanti, Francesco; Serviddio, Gaetano
Molecular Aspects and Treatment of Iron Deficiency in the Elderly
2020-01-01 Romano, A. D.; Paglia, A.; Bellanti, F.; Villani, R.; Sangineto, M.; Vendemiale, G.; Serviddio, G.
Lipid metabolism in development and progression of hepatocellular carcinoma
2020-01-01 Sangineto, M.; Villani, R.; Cavallone, F.; Romano, A.; Loizzi, D.; Serviddio, G.
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy?
2020-01-01 Villani, R.; Cavallone, F.; Sangineto, M.; Fioravanti, G.; Romano, A. D.; Serviddio, G.
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy?
2020-01-01 Villani, R.; Cavallone, F.; Sangineto, M.; Fioravanti, G.; Romano, A. D.; Serviddio, G.
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients
2020-01-01 Lombardi, R; Airaghi, L; Targher, G; Serviddio, G; Maffi, G; Mantovani, A; Maffeis, C; Colecchia, A; Villani, R; Rinaldi, L; Orsi, E; Pisano, G; Adinolfi, Le; Fargion, S; Fracanzani, Al
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease
2020-01-01 Bukke, V. N.; Villani, R.; Archana, M.; Wawrzyniak, A.; Balawender, K.; Orkisz, S.; Ferraro, L.; Serviddio, G.; Cassano, T.
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes
2020-01-01 Lombardi, R.; Airaghi, L.; Targher, G.; Serviddio, G.; Maffi, G.; Mantovani, A.; Maffeis, C.; Colecchia, A.; Villani, R.; Rinaldi, L.; Orsi, E.; Pisano, G.; Adinolfi, L. E.; Fargion, S.; Fracanzani, A. L.
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
2020-01-01 Lombardi, R.; Airaghi, L.; Targher, G.; Serviddio, G.; Maffi, G.; Mantovani, A.; Maffeis, C.; Colecchia, A.; Villani, R.; Rinaldi, L.; Orsi, E.; Pisano, G.; Adinolfi, L. E.; Fargion, S.; Fracanzani, A. L.
DIRECT-ACTING antivirals restore systemic redox homeostasis in chronic HCV patients
2020-01-01 Villani, Rosanna; Bellanti, Francesco; Cavallone, Francesco; Di Bello, Giorgia; Tamborra, Rosanna; Bukke Vidyasagar, Naik; Moola, Archana; Serviddio, Gaetano
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients
2020-01-01 Lombardi, R; Airaghi, L; Targher, G; Serviddio, G; Maffi, G; Mantovani, A; Maffeis, C; Colecchia, A; Villani, R; Rinaldi, L; Orsi, E; Pisano, G; Adinolfi, Le; Fargion, S; Fracanzani, Al
Tocilizumab and liver injury in patients with COVID-19
2020-01-01 Serviddio, G.; Villani, R.; Stallone, G.; Scioscia, G.; Foschino-Barbaro, M. P.; Lacedonia, D.
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
2020-01-01 Cassano, T.; Villani, R.; Pace, L.; Carbone, A.; Bukke, V. N.; Orkisz, S.; Avolio, C.; Serviddio, G.
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy
2020-01-01 Bukke, V. N.; Archana, M.; Villani, R.; Romano, A. D.; Wawrzyniak, A.; Balawender, K.; Orkisz, S.; Beggiato, S.; Serviddio, G.; Cassano, T.
Molecular Aspects and Treatment of Iron Deficiency in the Elderly
2020-01-01 Romano, A. D.; Paglia, A.; Bellanti, F.; Villani, R.; Sangineto, M.; Vendemiale, G.; Serviddio, G.
Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis
2021-01-01 Facciorusso, Antonio; Tartaglia, Nicola; Villani, Rosanna; Serviddio, Gaetano; Ramai, Daryl; Mohan, Babu P; Chandan, Saurabh; Abd El Aziz, Mohamed A; Evangelista, Jessica; Cotsoglou, Christian; Ambrosi, Antonio
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
2021-01-01 Munoz-Martinez, S.; Sapena, V.; Forner, A.; Nault, J. -C.; Sapisochin, G.; Rimassa, L.; Sangro, B.; Bruix, J.; Sanduzzi-Zamparelli, M.; Holowko, W.; El Kassas, M.; Mocan, T.; Bouattour, M.; Merle, P.; Hoogwater, F. J. H.; Alqahtani, S. A.; Reeves, H. L.; Pinato, D. J.; Giorgakis, E.; Meyer, T.; Villadsen, G. E.; Wege, H.; Salati, M.; Minguez, B.; Di Costanzo, G. G.; Roderburg, C.; Tacke, F.; Varela, M.; Galle, P. R.; Alvares-da-Silva, M. R.; Trojan, J.; Bridgewater, J.; Cabibbo, G.; Toso, C.; Lachenmayer, A.; Casadei-Gardini, A.; Toyoda, H.; Ludde, T.; Villani, R.; Matilla Pena, A. M.; Guedes Leal, C. R.; Ronzoni, M.; Delgado, M.; Perello, C.; Pascual, S.; Lledo, J. L.; Argemi, J.; Basu, B.; da Fonseca, L.; Acevedo, J.; Siebenhuner, A. R.; Braconi, C.; Meyers, B. M.; Granito, A.; Sala, M.; Rodriguez-Lope, C.; Blaise, L.; Romero-Gomez, M.; Pinero, F.; Gomez, D.; Mello, V.; Pinheiro Alves, R. C.; Franca, A.; Branco, F.; Brandi, G.; Pereira, G.; Coll, S.; Guarino, M.; Benitez, C.; Anders, M. M.; Bandi, J. C.; Vergara, M.; Calvo, M.; Peck-Radosavljevic, M.; Garcia-Juarez, I.; Cardinale, V.; Lozano, M.; Gambato, M.; Okolicsanyi, S.; Morales-Arraez, D.; Elvevi, A.; Munoz, A. E.; Lue, A.; Iavarone, M.; Reig, M.
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases
2021-01-01 Cornacchia, M. G.; Sangineto, M.; Villani, R.; Cavallone, F.; Di Gioia, G.; Cicciomessere, P.; Serviddio, G.
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression
2021-01-01 Dallio, M.; Sangineto, M.; Romeo, M.; Villani, R.; Romano, A. D.; Loguercio, C.; Serviddio, G.; Federico, A.
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy
2021-01-01 Villani, R.; Magnati, G. P.; De Girolamo, G.; Sangineto, M.; Romano, A. D.; Cassano, T.; Serviddio, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Two-Dimensional Shear Wave Elastography Versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C | 1-gen-2020 | Villani, Rosanna; Cavallone, Francesco; Romano, ANTONINO DAVIDE; Bellanti, Francesco; Serviddio, Gaetano | |
| Molecular Aspects and Treatment of Iron Deficiency in the Elderly | 1-gen-2020 | Romano, A. D.; Paglia, A.; Bellanti, F.; Villani, R.; Sangineto, M.; Vendemiale, G.; Serviddio, G. | |
| Lipid metabolism in development and progression of hepatocellular carcinoma | 1-gen-2020 | Sangineto, M.; Villani, R.; Cavallone, F.; Romano, A.; Loizzi, D.; Serviddio, G. | |
| Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? | 1-gen-2020 | Villani, R.; Cavallone, F.; Sangineto, M.; Fioravanti, G.; Romano, A. D.; Serviddio, G. | |
| Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? | 1-gen-2020 | Villani, R.; Cavallone, F.; Sangineto, M.; Fioravanti, G.; Romano, A. D.; Serviddio, G. | |
| NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients | 1-gen-2020 | Lombardi, R; Airaghi, L; Targher, G; Serviddio, G; Maffi, G; Mantovani, A; Maffeis, C; Colecchia, A; Villani, R; Rinaldi, L; Orsi, E; Pisano, G; Adinolfi, Le; Fargion, S; Fracanzani, Al | |
| The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease | 1-gen-2020 | Bukke, V. N.; Villani, R.; Archana, M.; Wawrzyniak, A.; Balawender, K.; Orkisz, S.; Ferraro, L.; Serviddio, G.; Cassano, T. | |
| NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes | 1-gen-2020 | Lombardi, R.; Airaghi, L.; Targher, G.; Serviddio, G.; Maffi, G.; Mantovani, A.; Maffeis, C.; Colecchia, A.; Villani, R.; Rinaldi, L.; Orsi, E.; Pisano, G.; Adinolfi, L. E.; Fargion, S.; Fracanzani, A. L. | |
| Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes | 1-gen-2020 | Lombardi, R.; Airaghi, L.; Targher, G.; Serviddio, G.; Maffi, G.; Mantovani, A.; Maffeis, C.; Colecchia, A.; Villani, R.; Rinaldi, L.; Orsi, E.; Pisano, G.; Adinolfi, L. E.; Fargion, S.; Fracanzani, A. L. | |
| DIRECT-ACTING antivirals restore systemic redox homeostasis in chronic HCV patients | 1-gen-2020 | Villani, Rosanna; Bellanti, Francesco; Cavallone, Francesco; Di Bello, Giorgia; Tamborra, Rosanna; Bukke Vidyasagar, Naik; Moola, Archana; Serviddio, Gaetano | |
| NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients | 1-gen-2020 | Lombardi, R; Airaghi, L; Targher, G; Serviddio, G; Maffi, G; Mantovani, A; Maffeis, C; Colecchia, A; Villani, R; Rinaldi, L; Orsi, E; Pisano, G; Adinolfi, Le; Fargion, S; Fracanzani, Al | |
| Tocilizumab and liver injury in patients with COVID-19 | 1-gen-2020 | Serviddio, G.; Villani, R.; Stallone, G.; Scioscia, G.; Foschino-Barbaro, M. P.; Lacedonia, D. | |
| From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases | 1-gen-2020 | Cassano, T.; Villani, R.; Pace, L.; Carbone, A.; Bukke, V. N.; Orkisz, S.; Avolio, C.; Serviddio, G. | |
| The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy | 1-gen-2020 | Bukke, V. N.; Archana, M.; Villani, R.; Romano, A. D.; Wawrzyniak, A.; Balawender, K.; Orkisz, S.; Beggiato, S.; Serviddio, G.; Cassano, T. | |
| Molecular Aspects and Treatment of Iron Deficiency in the Elderly | 1-gen-2020 | Romano, A. D.; Paglia, A.; Bellanti, F.; Villani, R.; Sangineto, M.; Vendemiale, G.; Serviddio, G. | |
| Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis | 1-gen-2021 | Facciorusso, Antonio; Tartaglia, Nicola; Villani, Rosanna; Serviddio, Gaetano; Ramai, Daryl; Mohan, Babu P; Chandan, Saurabh; Abd El Aziz, Mohamed A; Evangelista, Jessica; Cotsoglou, Christian; Ambrosi, Antonio | |
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) | 1-gen-2021 | Munoz-Martinez, S.; Sapena, V.; Forner, A.; Nault, J. -C.; Sapisochin, G.; Rimassa, L.; Sangro, B.; Bruix, J.; Sanduzzi-Zamparelli, M.; Holowko, W.; El Kassas, M.; Mocan, T.; Bouattour, M.; Merle, P.; Hoogwater, F. J. H.; Alqahtani, S. A.; Reeves, H. L.; Pinato, D. J.; Giorgakis, E.; Meyer, T.; Villadsen, G. E.; Wege, H.; Salati, M.; Minguez, B.; Di Costanzo, G. G.; Roderburg, C.; Tacke, F.; Varela, M.; Galle, P. R.; Alvares-da-Silva, M. R.; Trojan, J.; Bridgewater, J.; Cabibbo, G.; Toso, C.; Lachenmayer, A.; Casadei-Gardini, A.; Toyoda, H.; Ludde, T.; Villani, R.; Matilla Pena, A. M.; Guedes Leal, C. R.; Ronzoni, M.; Delgado, M.; Perello, C.; Pascual, S.; Lledo, J. L.; Argemi, J.; Basu, B.; da Fonseca, L.; Acevedo, J.; Siebenhuner, A. R.; Braconi, C.; Meyers, B. M.; Granito, A.; Sala, M.; Rodriguez-Lope, C.; Blaise, L.; Romero-Gomez, M.; Pinero, F.; Gomez, D.; Mello, V.; Pinheiro Alves, R. C.; Franca, A.; Branco, F.; Brandi, G.; Pereira, G.; Coll, S.; Guarino, M.; Benitez, C.; Anders, M. M.; Bandi, J. C.; Vergara, M.; Calvo, M.; Peck-Radosavljevic, M.; Garcia-Juarez, I.; Cardinale, V.; Lozano, M.; Gambato, M.; Okolicsanyi, S.; Morales-Arraez, D.; Elvevi, A.; Munoz, A. E.; Lue, A.; Iavarone, M.; Reig, M. | |
| High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases | 1-gen-2021 | Cornacchia, M. G.; Sangineto, M.; Villani, R.; Cavallone, F.; Di Gioia, G.; Cicciomessere, P.; Serviddio, G. | |
| Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression | 1-gen-2021 | Dallio, M.; Sangineto, M.; Romeo, M.; Villani, R.; Romano, A. D.; Loguercio, C.; Serviddio, G.; Federico, A. | |
| Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy | 1-gen-2021 | Villani, R.; Magnati, G. P.; De Girolamo, G.; Sangineto, M.; Romano, A. D.; Cassano, T.; Serviddio, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile